These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 1552035
1. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Tollefson GD, Montague-Clouse J, Tollefson SL. J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035 [Abstract] [Full Text] [Related]
2. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. Tollefson GD, Lancaster SP, Montague-Clouse J. Psychopharmacol Bull; 1991 Feb; 27(2):163-70. PubMed ID: 1924664 [Abstract] [Full Text] [Related]
4. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG. J Clin Psychiatry; 1997 Feb; 58 Suppl 11():19-23. PubMed ID: 9363044 [Abstract] [Full Text] [Related]
17. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Landén M, Eriksson O, Sundblad C, Andersch B, Naessén T, Eriksson E. Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692 [Abstract] [Full Text] [Related]
19. Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety. Tollefson GD, Godes M, Montague-Clouse J, Lancaster SP, Garvey MJ. J Clin Psychopharmacol; 1989 Apr; 9(2):132-6. PubMed ID: 2723131 [Abstract] [Full Text] [Related]